ZA954128B - Chewable flubendazole tablets for companion animals - Google Patents

Chewable flubendazole tablets for companion animals

Info

Publication number
ZA954128B
ZA954128B ZA954128A ZA954128A ZA954128B ZA 954128 B ZA954128 B ZA 954128B ZA 954128 A ZA954128 A ZA 954128A ZA 954128 A ZA954128 A ZA 954128A ZA 954128 B ZA954128 B ZA 954128B
Authority
ZA
South Africa
Prior art keywords
flubendazole
companion animals
pct
chewable
tablets
Prior art date
Application number
ZA954128A
Other languages
English (en)
Inventor
Eugene Marie Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA954128B publication Critical patent/ZA954128B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA954128A 1994-05-20 1995-05-19 Chewable flubendazole tablets for companion animals ZA954128B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20

Publications (1)

Publication Number Publication Date
ZA954128B true ZA954128B (en) 1996-11-19

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954128A ZA954128B (en) 1994-05-20 1995-05-19 Chewable flubendazole tablets for companion animals

Country Status (23)

Country Link
US (1) US5824336A (fr)
EP (1) EP0760648B1 (fr)
JP (1) JPH10501211A (fr)
AT (1) ATE208611T1 (fr)
AU (1) AU690994B2 (fr)
BR (1) BR9507637A (fr)
CA (1) CA2190357C (fr)
CY (1) CY2255B1 (fr)
CZ (1) CZ290406B6 (fr)
DE (1) DE69523912T2 (fr)
DK (1) DK0760648T3 (fr)
ES (1) ES2167436T3 (fr)
FI (1) FI118324B (fr)
HK (1) HK1010695A1 (fr)
HU (1) HU225958B1 (fr)
IL (1) IL113782A (fr)
NO (1) NO313402B1 (fr)
NZ (1) NZ285766A (fr)
PL (1) PL185332B1 (fr)
PT (1) PT760648E (fr)
SI (1) SI0760648T1 (fr)
WO (1) WO1995031963A1 (fr)
ZA (1) ZA954128B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
WO2001021178A2 (fr) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Procede destine a traiter le syndrome de dysfonctionnement cognitif chez le chien et comprimes a croquer pour chiens
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (fr) * 2003-03-10 2007-09-12 Novartis AG Compositions solides veterinaires à goût masqué
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
CZ17621U1 (cs) 2003-08-26 2007-06-25 Shire Holdings Ag Farmaceutický prostredek zahrnující slouceniny lanthanu
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
WO2010132286A1 (fr) * 2009-05-12 2010-11-18 Wyeth Llc Préparation en comprimé administrée par voie orale d'un composé antianxiolytique
AU2013217633B2 (en) 2012-02-06 2017-01-12 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
AU2013245011B2 (en) 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
BR112015023435B1 (pt) 2013-03-15 2022-05-03 Douglas Robert Cleverly Formulação mastigável estável sob armazenagem e método de fabricação de uma formulação mastigável, palatável e estável sob armazenagem
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
WO2015082389A1 (fr) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Compositions pharmaceutiques améliorées de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
FI964623A (fi) 1996-11-19
WO1995031963A1 (fr) 1995-11-30
PT760648E (pt) 2002-04-29
FI964623A0 (fi) 1996-11-19
AU690994B2 (en) 1998-05-07
CY2255B1 (en) 2003-07-04
NO964912L (no) 1996-11-19
NO313402B1 (no) 2002-09-30
JPH10501211A (ja) 1998-02-03
PL317227A1 (en) 1997-03-17
ES2167436T3 (es) 2002-05-16
DE69523912D1 (de) 2001-12-20
CA2190357A1 (fr) 1995-11-30
HU225958B1 (en) 2008-01-28
BR9507637A (pt) 1997-10-07
DK0760648T3 (da) 2002-02-25
CA2190357C (fr) 2007-04-17
NZ285766A (en) 1997-09-22
PL185332B1 (pl) 2003-04-30
CZ290406B6 (cs) 2002-07-17
FI118324B (fi) 2007-10-15
US5824336A (en) 1998-10-20
AU2527295A (en) 1995-12-18
IL113782A (en) 1999-08-17
HK1010695A1 (en) 1999-06-25
HU9603215D0 (en) 1997-01-28
CZ333596A3 (en) 1997-02-12
ATE208611T1 (de) 2001-11-15
EP0760648B1 (fr) 2001-11-14
IL113782A0 (en) 1995-08-31
NO964912D0 (no) 1996-11-19
HUT74988A (en) 1997-03-28
DE69523912T2 (de) 2002-06-27
SI0760648T1 (en) 2002-04-30
EP0760648A1 (fr) 1997-03-12

Similar Documents

Publication Publication Date Title
HUT74988A (en) Chewable flubendazole tablets for companion animals
HUT75123A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
YU21702A (sh) Supstituisani indoli za moduliranje nfkb aktivnosti
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
IL115920A0 (en) 2,2-dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
MX9803629A (es) 5-amino isotiazoles acilados con efecto insecticida, productos intermedios y proceso para su preparacion.
HU9602695D0 (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
IL165220A0 (en) Novel compounds, their use and preparation
MX2007003307A (es) 4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
MX9605709A (es) Tabletas masticables de flubendazol para animales de compañia.
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
AU6722498A (en) Disubstituted biphenyloxazolines
GB0003234D0 (en) Method of treatment